30.93 -0.58 (-1.84%)

New 52W Low in past week

435.5K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Janux Therapeutics Inc

The latest disclosure was made by Andrew Hollman Meyer in Janux Therapeutics Inc where a trade of 3,334 Stock Option (right to buy) done was reported to US exchanges on March 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Andrew Hollman Meyer Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2025 3,334 93,999 - - Stock Option (right to buy)
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 32.85 per share. 03 Mar 2025 901 82,139 - 32.9 29,599 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 31.88 per share. 03 Mar 2025 2,433 83,040 - 31.9 77,576 Common Stock
Andrew Hollman Meyer Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.21 per share. 03 Mar 2025 3,334 85,473 - 4.2 14,036 Common Stock
Andrew Hollman Meyer Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Feb 2025 3,334 97,333 - - Stock Option (right to buy)
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 43.60 per share. 03 Feb 2025 100 82,139 - 43.6 4,360 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 42.77 per share. 03 Feb 2025 816 82,239 - 42.8 34,901 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 42.08 per share. 03 Feb 2025 2,418 83,055 - 42.1 101,739 Common Stock
Andrew Hollman Meyer Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.21 per share. 03 Feb 2025 3,334 85,473 - 4.2 14,036 Common Stock
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 60.00 per share. 07 Jan 2025 5,000 293,054 - 60.0 300,004 Common Stock
David Campbell Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 283,500 283,500 - - Stock option (right to buy)
David Campbell Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 81,000 298,054 - 0 Common Stock
Byron Robinson Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 28,000 28,000 - 0 Common Stock
Byron Robinson Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 98,000 98,000 - - Stock option (right to buy)
Charles M. Winter Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 80,500 80,500 - - Stock option (right to buy)
Charles M. Winter Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 23,000 77,288 - 0 Common Stock
Andrew Hollman Meyer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 63,000 63,000 - - Stock option (right to buy)
Andrew Hollman Meyer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 18,000 95,473 - 0 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 53.76 per share. 02 Jan 2025 2,922 92,551 - 53.8 157,081 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 54.51 per share. 02 Jan 2025 5,768 86,783 - 54.5 314,420 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 55.76 per share. 02 Jan 2025 3,444 83,339 - 55.8 192,033 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 56.78 per share. 02 Jan 2025 1,000 82,339 - 56.8 56,778 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 57.36 per share. 02 Jan 2025 200 82,139 - 57.4 11,473 Common Stock
Thomas DiRaimondo Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 24,000 129,719 - 0 Common Stock
Thomas DiRaimondo Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 84,000 84,000 - - Stock option (right to buy)
Maria Dobek Vice President, Accounting 02 Jan 2025 31,500 31,500 - - Stock option (right to buy)
Maria Dobek Vice President, Accounting 02 Jan 2025 14,000 14,001 - 0 Common Stock
Zachariah McIver Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 26,000 26,000 - 0 Common Stock
Zachariah McIver Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 91,000 91,000 - - Stock option (right to buy)
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 56.19 per share. 24 Dec 2024 25,000 217,054 - 56.2 1,404,805 Common Stock
Hollman Meyer Andrew Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.24 per share. 19 Dec 2024 9,880 77,472 - 20.2 199,971 Common Stock
Hollman Andrew Meyer Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2024 1 89,999 - - Stock Option (right to buy)
Andrew Hollman Meyer Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.00 per share. 19 Dec 2024 1 77,473 - 14 14 Common Stock
Meyer Hollman Andrew Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Dec 2024 9,880 96,870 - - Stock Option (right to buy)
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 67.00 per share. 03 Dec 2024 15,000 242,054 - 67 1,005,000 Common Stock
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 52.04 per share. 25 Nov 2024 6,719 257,054 - 52.0 349,647 Common Stock
Campbell David Director, President and CEO Sale of securities on an exchange or to another person at price $ 51.43 per share. 25 Nov 2024 18,281 263,773 - 51.4 940,232 Common Stock
Vickie L. Capps Director Other type of transaction at price $ 0.00 per share. 05 Nov 2024 2,305 70,348 - 0 Common Stock
Sheila Gujrathi Director Other type of transaction at price $ 0.00 per share. 05 Nov 2024 4,611 115,139 - 0 Common Stock
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 53.22 per share. 28 Oct 2024 13,897 293,157 - 53.2 739,650 Common Stock
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 53.94 per share. 28 Oct 2024 11,103 282,054 - 53.9 598,909 Common Stock
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 47.84 per share. 27 Sep 2024 795 307,054 - 47.8 38,032 Common Stock
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 46.09 per share. 27 Sep 2024 18,957 313,097 - 46.1 873,715 Common Stock
David Campbell Director, President and CEO Sale of securities on an exchange or to another person at price $ 46.85 per share. 27 Sep 2024 5,248 307,849 - 46.9 245,895 Common Stock
Andrew Hollman Meyer Chief Business Officer Sale of securities on an exchange or to another person at price $ 45.96 per share. 27 Sep 2024 50,000 67,592 - 46.0 2,297,755 Common Stock
Andrew Hollman Meyer Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Sep 2024 50,000 100,667 - - Stock Option (right to buy)
Andrew Hollman Meyer Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.21 per share. 27 Sep 2024 50,000 117,592 - 4.2 210,500 Common Stock
Thomas DiRaimondo Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 46.21 per share. 27 Sep 2024 4,325 98,613 - 46.2 199,840 Common Stock
Thomas DiRaimondo Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 47.23 per share. 27 Sep 2024 675 97,938 - 47.2 31,877 Common Stock
Jay Lichter Ten Percent Owner Sale of securities on an exchange or to another person at price $ 46.68 per share. 13 Sep 2024 3,815 7,000 - 46.7 178,084 Common Stock
Jay Lichter Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.80 per share. 13 Sep 2024 391 10,815 - 39.8 15,562 Common Stock
Jay Lichter Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.22 per share. 13 Sep 2024 778 10,424 - 13.2 10,285 Common Stock
Jay Lichter Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.73 per share. 13 Sep 2024 778 9,646 - 10.7 8,348 Common Stock
Jay Lichter Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. 13 Sep 2024 1,868 8,868 - 17 31,756 Common Stock
Jay Lichter Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2024 778 11,308 - - Stock Option (right to buy)
Jay Lichter Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2024 778 11,308 - - Stock Option (right to buy)
Jay Lichter Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2024 391 7,682 - - Stock Option (right to buy)
Jay Lichter Ten Percent Owner Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Sep 2024 1,868 27,138 - - Stock Option (right to buy)
Eric L. Dobmeier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 5,000 5,000 - 0 Common Stock
Eric L. Dobmeier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 8,350 8,350 - - Stock Option (Right to Buy)
Eric L. Dobmeier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 16,700 16,700 - - Stock Option (Right to Buy)
Eric L. Dobmeier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 2,500 7,500 - 0 Common Stock
Natasha A. Hernday Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 2,500 7,500 - 0 Common Stock
Natasha A. Hernday Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 8,350 8,350 - - Stock Option (Right to Buy)
Natasha A. Hernday Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 16,700 16,700 - - Stock Option (Right to Buy)
Natasha A. Hernday Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 5,000 5,000 - 0 Common Stock
Eric L. Dobmeier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 4,111 4,111 - - Stock Option (Right to Buy)
Eric L. Dobmeier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 1,231 6,231 - 0 Common Stock
Natasha A. Hernday Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 4,111 4,111 - - Stock Option (Right to Buy)
Natasha A. Hernday Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2024 1,231 6,231 - 0 Common Stock
Ronald W. Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 2,500 2,500 - 0 Common Stock
Ronald W. Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 8,350 8,350 - - Stock Option (right to buy)
Vickie L. Capps Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 2,500 68,043 - 0 Common Stock
Vickie L. Capps Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 8,350 8,350 - - Stock Option (right to buy)
Jay Lichter Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 2,500 7,083 - 0 Common Stock
Jay Lichter Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 8,350 8,350 - - Stock Option (right to buy)
Sheila Gujrathi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 8,350 8,350 - - Stock Option (right to buy)
Sheila Gujrathi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 2,500 110,528 - 0 Common Stock
Winston Kung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 2,500 2,500 - 0 Common Stock
Winston Kung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 8,350 8,350 - - Stock Option (right to buy)
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 2,500 2,500 - 0 Common Stock
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 8,350 8,350 - - Stock Option (right to buy)
Alana B. McNulty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 8,350 8,350 - - Stock Option (right to buy)
Alana B. McNulty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 2,500 2,500 - 0 Common Stock
Jay Lichter Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 54.75 per share. 03 Jun 2024 677,279 3,271,216 - 54.7 37,081,025 Common Stock
Jay Lichter Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 54.75 per share. 03 Jun 2024 691,525 3,340,018 - 54.8 37,860,994 Common Stock
Jay Lichter Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 54.75 per share. 03 Jun 2024 131,196 633,673 - 54.8 7,182,981 Common Stock
Tighe Reardon Acting Chief Financial Officer Sale of securities on an exchange or to another person at price $ 54.75 per share. 03 Jun 2024 131,196 633,673 - 54.8 7,182,981 Common Stock
Tighe Reardon Acting Chief Financial Officer Sale of securities on an exchange or to another person at price $ 54.75 per share. 03 Jun 2024 691,525 3,340,018 - 54.8 37,860,994 Common Stock
Vickie L. Capps Director Other type of transaction at price $ 0.00 per share. 29 Feb 2024 1,493 65,543 - 0 Common Stock
Sheila Gujrathi Director Other type of transaction at price $ 0.00 per share. 29 Feb 2024 2,986 108,028 - 0 Common Stock
DiRaimondo Thomas Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 147,000 147,000 - - Stock Option (right to buy)
Meyer Hollman Andrew Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 105,000 105,000 - - Stock Option (right to buy)
Campbell David Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 356,500 356,500 - - Stock Option (right to buy)
Winter M. Charles Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 111,000 111,000 - - Stock Option (right to buy)
Robinson Byron Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 151,500 151,500 - - Stock Option (right to buy)
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 157,000 157,000 - - Stock Option (right to buy)
Jay Lichter Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 5.87 per share. 13 Nov 2023 849,854 849,854 - 5.9 4,988,643 Common Stock
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 5.87 per share. 13 Nov 2023 849,854 849,854 - 5.9 4,988,643 Common Stock
Ronald W. Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 12,500 - - Stock Option (right to buy)
Vickie L. Capps Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 12,500 - - Stock Option (right to buy)
Jay Lichter Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 12,500 - - Stock Option (right to buy)
Sheila Gujrathi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 12,500 - - Stock Option (right to buy)
Winston Kung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 12,500 - - Stock Option (right to buy)
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 12,500 - - Stock Option (right to buy)
Alana B. McNulty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2023 12,500 12,500 - - Stock Option (right to buy)
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 110,000 110,000 - - Stock Option (right to buy)
Wayne Godfrey Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 110,000 110,000 - - Stock Option (right to buy)
David Campbell Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 310,000 310,000 - - Stock Option (right to buy)
Byron Robinson Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 100,000 100,000 - - Stock Option (right to buy)
Charles M. Winter Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 100,000 100,000 - - Stock Option (right to buy)
Andrew Hollman Meyer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 90,000 90,000 - - Stock Option (right to buy)
Winston Kung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Sep 2022 9,375 9,375 - - Stock Option (right to buy)
Winston Kung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Sep 2022 30,000 30,000 - - Stock Option (right to buy)
Peter A. Thompson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 12,500 12,500 - - Stock Option (right to buy)
Ronald W. Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 12,500 12,500 - - Stock Option (right to buy)
Vickie L. Capps Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 12,500 12,500 - - Stock Option (right to buy)
Jay Lichter Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 12,500 12,500 - - Stock Option (right to buy)
Sheila Gujrathi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 12,500 12,500 - - Stock Option (right to buy)
Stefan Heller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 12,500 12,500 - - Stock Option (right to buy)
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 12,500 12,500 - - Stock Option (right to buy)
Alana B. McNulty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2022 12,500 12,500 - - Stock Option (right to buy)
Byron Robinson Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 230,000 230,000 - - Stock Option (right to buy)
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 116,750 116,750 - - Stock Option (right to buy)
Wayne Godfrey Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 114,250 114,250 - - Stock Option (right to buy)
David Campbell Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 354,250 354,250 - - Stock Option (right to buy)
Shahram Salek-Ardakani Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 114,250 114,250 - - Stock Option (right to buy)
Andrew Hollman Meyer Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 106,750 106,750 - - Stock Option (right to buy)
Peter A. Thompson Director Sale of securities on an exchange or to another person at price $ 20.30 per share. 29 Dec 2021 3,700 231,098 - 20.3 75,110 Common Stock
Peter A. Thompson Director Sale of securities on an exchange or to another person at price $ 20.30 per share. 29 Dec 2021 36,700 2,258,566 - 20.3 745,010 Common Stock
Peter A. Thompson Director Sale of securities on an exchange or to another person at price $ 19.00 per share. 21 Dec 2021 11,100 234,798 - 19 210,900 Common Stock
Peter A. Thompson Director Sale of securities on an exchange or to another person at price $ 19.00 per share. 21 Dec 2021 108,300 2,295,266 - 19 2,057,700 Common Stock
Peter A. Thompson Director Sale of securities on an exchange or to another person at price $ 19.07 per share. 16 Dec 2021 356,800 2,403,566 - 19.1 6,804,176 Common Stock
Peter A. Thompson Director Sale of securities on an exchange or to another person at price $ 19.07 per share. 16 Dec 2021 36,500 245,898 - 19.1 696,055 Common Stock
Ronald W. Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Sep 2021 30,000 30,000 - - Stock Option (right to buy)
Alana B. McNulty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Sep 2021 30,000 30,000 - - Stock Option (right to buy)
Peter A. Thompson Director 15 Jun 2021 128,609 0 - - Series B Convertible Preferred Stock
Peter A. Thompson Director 15 Jun 2021 643,046 0 - - Series B Convertible Preferred Stock
Peter A. Thompson Director 15 Jun 2021 1,052,632 0 - - Series A Convertible Preferred Stock
Peter A. Thompson Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 15 Jun 2021 117,650 282,398 - 17 2,000,050 Common Stock
Peter A. Thompson Director 15 Jun 2021 164,748 164,748 - - Common Stock
Peter A. Thompson Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 15 Jun 2021 588,203 2,760,366 - 17 9,999,451 Common Stock
Peter A. Thompson Director 15 Jun 2021 823,742 2,172,163 - - Common Stock
Peter A. Thompson Director 15 Jun 2021 1,348,421 1,348,421 - - Common Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 2,382,191 3,713,006 - - Common Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 900,264 0 - - Series B Convertible Preferred Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 2,105,264 0 - - Series A Convertible Preferred Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 526,316 0 - - Series A Convertible Preferred Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 1,859,634 0 - - Series Seed 2 Convertible Preferred Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 888,888 0 - - Series Seed Convertible Preferred Stock
Jay Lichter Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 17.00 per share. 15 Jun 2021 629,411 4,479,492 - 17 10,699,987 Common Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 1,153,238 3,850,081 - - Common Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 2,696,843 2,696,843 - - Common Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 674,211 4,387,217 - - Common Stock
Jay Lichter Director, Ten Percent Owner 15 Jun 2021 1,138,665 1,330,815 - - Common Stock
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner 15 Jun 2021 1,153,238 3,850,081 - - Common Stock
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner 15 Jun 2021 2,696,843 2,696,843 - - Common Stock
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 17.00 per share. 15 Jun 2021 629,411 4,479,492 - 17 10,699,987 Common Stock
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner 15 Jun 2021 2,105,264 0 - - Series A Convertible Preferred Stock
Tighe Reardon Acting Chief Financial Officer, Ten Percent Owner 15 Jun 2021 900,264 0 - - Series B Convertible Preferred Stock
Peter A. Thompson Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
Jay Lichter Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 30,000 30,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures